EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Hidradenitis Suppurativa Living International Guidelines for Advanced Targeted Therapies

Cathryn Sibbald, Helene Veillette, Nujud Al-Jabouri, Hadeel Al-Kofahi, Eunice Aluko, Naila Bouadi, Farida Benhadou, Yousef Binamer, Alain Brassard, Nisha Suyien Chandran, Serena Dienes, John W. Frew und 23 weitere

Journal of Cutaneous Medicine and Surgery · 19.11.2026

DOI: 10.1177/12034754261492667 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Cutaneous Medicine and Surgery, online erschienen am 19.11.2026. Verfasst von Cathryn Sibbald und 34 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple advanced therapies have been studied in patients with hidradenitis suppurativa (HS), but current treatment guidelines are not able to keep up with the rate of new published evidence for these agents.

Objective

To develop and apply a framework for living international evidence-based guidelines housed on a dedicated and accessible internet platform for the approach and management of patients with HS.

Methods

A steering committee supervised literature searches, screening, data extraction, and development of statements using the Grading of Recommendations Assessment, Development, and Evaluation framework. An electronic e-Delphi process was used to adopt recommendations using an a priori determined cut-off of 70% agreement.

Results

Eighteen experts from 10 countries participated in the e-Delphi voting from September to December 2025. Statements included treatment with inhibitors of tumor necrosis factor, interleukin-17 (IL-17), IL-1, IL-12/IL-23, and Janus kinases. Of 18 recommendations, 11 were adopted in the first round and 6 in the second round. One recommendation was omitted.

Conclusions

These current recommendations provide important practical guidance on the selection and use of advanced therapies in the management of patients with HS, based on current evidence. They include advice for selection of off-label agents when approved medications are contraindicated or fail, and will be updated on an ongoing basis with regularly planned searches to identify and incorporate new data.

Zitieren

APA

Sibbald, C., Veillette, H., Al-Jabouri, N., Al-Kofahi, H., Aluko, E., Bouadi, N., Benhadou, F., Binamer, Y., Brassard, A., Chandran, N. S., Dienes, S., Frew, J. W., Groleau, A., Jemec, G. B., Land, H., Lamb, J., Lima, H., Lordfard, S., Malawi, I., …, & Alhusayen, R. (2026). Hidradenitis Suppurativa Living International Guidelines for Advanced Targeted Therapies. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754261492667

Vancouver

Sibbald C, Veillette H, Al-Jabouri N, Al-Kofahi H, Aluko E, Bouadi N, et al. Hidradenitis Suppurativa Living International Guidelines for Advanced Targeted Therapies. Journal of Cutaneous Medicine and Surgery. 2026. doi:10.1177/12034754261492667

BibTeX
@article{Sibbald2026,
  author = {Sibbald, Cathryn and Veillette, Helene and Al-Jabouri, Nujud and Al-Kofahi, Hadeel and Aluko, Eunice and Bouadi, Naila and Benhadou, Farida and Binamer, Yousef and Brassard, Alain and Chandran, Nisha Suyien and Dienes, Serena and Frew, John W. and Groleau, Anne-Sophie and Jemec, Gregor B. and Land, Hailey and Lamb, Jillian and Lima, Hermenio and Lordfard, Sanaz and Malawi, Ibtihal and Martorell, Antonio and Marzano, Angelo V. and Mitwalli, Mohammed and Mohsen, Samiha and Park, Megan and Peri, Katya and Poelman, Susan and Prens, Errol P. and Shaikh, Rahila and Sy, Sheena and Turchin, Irina and Wiseman, Marni and Wong, Se Mang and Xiong, Grace and Youakim, Mina and Alhusayen, Raed},
  title = {Hidradenitis Suppurativa Living International Guidelines for Advanced Targeted Therapies},
  journal = {Journal of Cutaneous Medicine and Surgery},
  year = {2026},
  doi = {10.1177/12034754261492667}
}
Kostenlos starten →